Clinical Trial Update: Prospective triAl of Modified Treat-and-extend Regimens With BroLucizumab in pachychOroid Neovasculopathy [Phase 3]

View source ↗

Summary

Phase 3 trial investigating BroLucizumab in pachychoroid neovasculopathy and age-related macular degeneration is currently in an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Pachychoroid Neovasculopathy

Drugs mentioned

• Brolucizumab (brolucizumab)

Snippet

Sponsor: Yeungnam University College of Medicine | Conditions: Age-Related Macular Degeneration, Pachychoroid Neovasculopathy | Phase 3 | Status: UNKNOWN